Literature DB >> 24529750

Tumor evolution in response to chemotherapy: phenotype versus genotype.

Nicholas E Navin1.   

Abstract

In this issue of Cell Reports, Almendro et al. report one of the first comprehensive studies on the intratumor heterogeneity of cell phenotypes and genotypes before and after chemotherapy in breast cancer. These data challenge the concept of genetic population bottlenecks and suggest that cellular phenotypes play an important role in developing resistance to therapy.
Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24529750      PMCID： PMC5558200          DOI： 10.1016/j.celrep.2014.01.035

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  10 in total

Review 1.  Cancer as an evolutionary and ecological process.

Authors:  Lauren M F Merlo; John W Pepper; Brian J Reid; Carlo C Maley
Journal:  Nat Rev Cancer       Date:  2006-11-16       Impact factor: 60.716

2.  The clonal evolution of tumor cell populations.

Authors:  P C Nowell
Journal:  Science       Date:  1976-10-01       Impact factor: 47.728

3.  EGFR mutation heterogeneity and the mixed response to EGFR tyrosine kinase inhibitors of lung adenocarcinomas.

Authors:  Zhi-Yong Chen; Wen-Zhao Zhong; Xu-Chao Zhang; Jian Su; Xue-Ning Yang; Zhi-Hong Chen; Jin-Ji Yang; Qing Zhou; Hong-Hong Yan; She-Juan An; Hua-Jun Chen; Ben-Yuan Jiang; Tony S Mok; Yi-Long Wu
Journal:  Oncologist       Date:  2012-06-06

4.  Inferring tumor progression from genomic heterogeneity.

Authors:  Nicholas Navin; Alexander Krasnitz; Linda Rodgers; Kerry Cook; Jennifer Meth; Jude Kendall; Michael Riggs; Yvonne Eberling; Jennifer Troge; Vladimir Grubor; Dan Levy; Pär Lundin; Susanne Månér; Anders Zetterberg; James Hicks; Michael Wigler
Journal:  Genome Res       Date:  2009-11-10       Impact factor: 9.043

5.  Inference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversity.

Authors:  Vanessa Almendro; Yu-Kang Cheng; Amanda Randles; Shalev Itzkovitz; Andriy Marusyk; Elisabet Ametller; Xavier Gonzalez-Farre; Montse Muñoz; Hege G Russnes; Aslaug Helland; Inga H Rye; Anne-Lise Borresen-Dale; Reo Maruyama; Alexander van Oudenaarden; Mitchell Dowsett; Robin L Jones; Jorge Reis-Filho; Pere Gascon; Mithat Gönen; Franziska Michor; Kornelia Polyak
Journal:  Cell Rep       Date:  2014-01-23       Impact factor: 9.423

6.  High intratumor genetic heterogeneity is related to worse outcome in patients with head and neck squamous cell carcinoma.

Authors:  Edmund A Mroz; Aaron D Tward; Curtis R Pickering; Jeffrey N Myers; Robert L Ferris; James W Rocco
Journal:  Cancer       Date:  2013-05-20       Impact factor: 6.860

7.  Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype.

Authors:  So Yeon Park; Mithat Gönen; Hee Jung Kim; Franziska Michor; Kornelia Polyak
Journal:  J Clin Invest       Date:  2010-01-25       Impact factor: 14.808

8.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.

Authors:  Marco Gerlinger; Andrew J Rowan; Stuart Horswell; James Larkin; David Endesfelder; Eva Gronroos; Pierre Martinez; Nicholas Matthews; Aengus Stewart; Charles Swanton; M Math; Patrick Tarpey; Ignacio Varela; Benjamin Phillimore; Sharmin Begum; Neil Q McDonald; Adam Butler; David Jones; Keiran Raine; Calli Latimer; Claudio R Santos; Mahrokh Nohadani; Aron C Eklund; Bradley Spencer-Dene; Graham Clark; Lisa Pickering; Gordon Stamp; Martin Gore; Zoltan Szallasi; Julian Downward; P Andrew Futreal
Journal:  N Engl J Med       Date:  2012-03-08       Impact factor: 91.245

9.  Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing.

Authors:  Li Ding; Timothy J Ley; David E Larson; Christopher A Miller; Daniel C Koboldt; John S Welch; Julie K Ritchey; Margaret A Young; Tamara Lamprecht; Michael D McLellan; Joshua F McMichael; John W Wallis; Charles Lu; Dong Shen; Christopher C Harris; David J Dooling; Robert S Fulton; Lucinda L Fulton; Ken Chen; Heather Schmidt; Joelle Kalicki-Veizer; Vincent J Magrini; Lisa Cook; Sean D McGrath; Tammi L Vickery; Michael C Wendl; Sharon Heath; Mark A Watson; Daniel C Link; Michael H Tomasson; William D Shannon; Jacqueline E Payton; Shashikant Kulkarni; Peter Westervelt; Matthew J Walter; Timothy A Graubert; Elaine R Mardis; Richard K Wilson; John F DiPersio
Journal:  Nature       Date:  2012-01-11       Impact factor: 49.962

Review 10.  The causes and consequences of genetic heterogeneity in cancer evolution.

Authors:  Rebecca A Burrell; Nicholas McGranahan; Jiri Bartek; Charles Swanton
Journal:  Nature       Date:  2013-09-19       Impact factor: 49.962
  10 in total
  26 in total

1.  The shock of being united and symphiliosis. Another lesson from plants?

Authors:  Yuri Lazebnik
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

2.  Clustering and classification methods for single-cell RNA-sequencing data.

Authors:  Ren Qi; Anjun Ma; Qin Ma; Quan Zou
Journal:  Brief Bioinform       Date:  2020-07-15       Impact factor: 11.622

3.  Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing.

Authors:  Charissa Kim; Ruli Gao; Emi Sei; Rachel Brandt; Johan Hartman; Thomas Hatschek; Nicola Crosetto; Theodoros Foukakis; Nicholas E Navin
Journal:  Cell       Date:  2018-04-19       Impact factor: 41.582

4.  Single-Cell RNA Sequencing of Ovarian Cancer: Promises and Challenges.

Authors:  Shobhana Talukdar; Zenas Chang; Boris Winterhoff; Timothy K Starr
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Oncogenic TRIM37 Links Chemoresistance and Metastatic Fate in Triple-Negative Breast Cancer.

Authors:  Piotr Przanowski; Song Lou; Rachisan Djiake Tihagam; Tanmoy Mondal; Caroline Conlan; Gururaj Shivange; Ilyas Saltani; Chandrajeet Singh; Kun Xing; Benjamin B Morris; Marty W Mayo; Luis Teixeira; Jacqueline Lehmann-Che; Jogender Tushir-Singh; Sanchita Bhatnagar
Journal:  Cancer Res       Date:  2020-08-27       Impact factor: 12.701

Review 6.  Analyzing Circulating Tumor Cells One at a Time.

Authors:  Veronica Ortiz; Min Yu
Journal:  Trends Cell Biol       Date:  2018-06-08       Impact factor: 20.808

Review 7.  Deciphering and Targeting Oncogenic Mutations and Pathways in Breast Cancer.

Authors:  Libero Santarpia; Giulia Bottai; Catherine M Kelly; Balázs Győrffy; Borbala Székely; Lajos Pusztai
Journal:  Oncologist       Date:  2016-07-06

8.  Modeling Tumor Evolutionary Dynamics to Predict Clinical Outcomes for Patients with Metastatic Colorectal Cancer: A Retrospective Analysis.

Authors:  Jiawei Zhou; Yutong Liu; Yubo Zhang; Quefeng Li; Yanguang Cao
Journal:  Cancer Res       Date:  2019-11-01       Impact factor: 12.701

Review 9.  Single cell RNA sequencing for breast cancer: present and future.

Authors:  Lili Ren; Junyi Li; Chuhan Wang; Zheqi Lou; Shuangshu Gao; Lingyu Zhao; Shuoshuo Wang; Anita Chaulagain; Minghui Zhang; Xiaobo Li; Jing Tang
Journal:  Cell Death Discov       Date:  2021-05-14

10.  Deciphering the cellular source of tumor relapse identifies CD44 as a major therapeutic target in pancreatic adenocarcinoma.

Authors:  Maria Inés Molejon; Juan Ignacio Tellechea; Celine Loncle; Odile Gayet; Marine Gilabert; Pauline Duconseil; Maria Belen Lopez-Millan; Vincent Moutardier; Mohamed Gasmi; Stephane Garcia; Olivier Turrini; Mehdi Ouaissi; Flora Poizat; Nelson Dusetti; Juan Iovanna
Journal:  Oncotarget       Date:  2015-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.